Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00188227
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 20, 2007
Information provided by:
Technische Universität Dresden

Brief Summary:
The purpose of this study is to investigate and compare the effects of three different methods for reducing pain and anxiety in adult patients undergoing puncture of the bone marrow. The investigated methods are: cognitive behavioural technique, administration of a sedative drug(Midazolam) and administration of an analgetic drug (Piritramid)prior to the procedure. Additionally, there are two comparison groups in which the patients receive either placebo treatment or no treatment at all.

Condition or disease Intervention/treatment Phase
Patients Undergoing Puncture of the Bone Marrow Drug: Midazolam (sedative) Drug: Piritramid (analgetic) Behavioral: Cognitive exercises Phase 4

Detailed Description:
The puncture of the bone marrow is a routine medical procedure which is often performed in the field of hematology/oncology. When carefully and appropriately performed, the puncture of the bone marrow has a very low rate of complications and is generally safe for the patient. However, it is an invasive and painful procedure associated with anxiety, especially in patients undergoing repeated punctures. Therefore an appropriate preparation of the patient for the puncture is essential in order to minimize the stress experienced during the procedure. In this regard, there are numbers of both pharmacological and non-pharmacological interventions in pedriatric patients aimed at reducing the punction related pain and anxiety in this patients. Nevertheless an evidence based approach for the pretreatment of the patients is yet to be established. The aim of this study is to investigate three different methods for reducing the pain and anxiety associated with the puncture of the bone marrow in adult patients. Two of the of the investigated methods involve pretreatment of the patients with pharmacological agents (sedative drug or analgetic drug), whereas the third method involves cognitive behavioural pretreatment in form of an audio material. The patients in the control group receive placebo injections.

Study Type : Interventional  (Clinical Trial)
Enrollment : 748 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture
Study Start Date : September 2001
Study Completion Date : November 2003

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Primary Outcome Measures :
  1. Reduction of pain and anxiety during and after the punction procedure
  2. Comparison of the efficacy of the three investigated methods to the placebo group, as well as to the group not receiving any pretreatment at all.

Secondary Outcome Measures :
  1. Duration of the effective pain reduction in each of the investigated groups
  2. Assessment of the quality of life in the period immediately after the bone marrow puncture

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients scheduled for both first or repeated punction of the bone marrow
  • Age between 18 and 85 years
  • Written informed consent

Exclusion Criteria:

  • Contraindication for a punction of the bone marrow
  • Administration of benzodiazepines or analgetic drugs prior to the bone marrow punction
  • Known hypersensitivity to benzodiazepines or Piritramid
  • Known contraindication to benzodiazepines (Myasthenia gravis in particular) or Piritramid (Pheochromocytoma or conditions affecting the consciousness)
  • Poor general condition (ECOG Performance Status 3,4; Karnofsky Index < 50%)
  • Addictive disorders
  • Administration of antidepressive drugs
  • Administration of drugs that potentially depress the respiratory function
  • Severe cardio-circulatory or respiratory insufficiency, sleep apnea syndrome
  • Known bradycardia
  • History of syncope(s) of unclear etiology
  • Pregnancy or lactation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00188227

Medizinische Klinik und Poliklinik I, University Clinic Carl Gustav Carus
Dresden, Sachsen, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Ralph Naumann, MD University Clinic "Carl Gustav Carus" Dresden

Publications: Identifier: NCT00188227     History of Changes
Other Study ID Numbers: CGC05MK1001
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 20, 2007
Last Verified: September 2005

Keywords provided by Technische Universität Dresden:
Bone marrow puncture

Additional relevant MeSH terms:
Wounds and Injuries
Hypnotics and Sedatives
Adjuvants, Anesthesia
Central Nervous System Depressants
Physiological Effects of Drugs
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
Anesthetics, Intravenous
Anesthetics, General
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Sensory System Agents
Peripheral Nervous System Agents